Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Lilly touts Foundayo’s early stages of obesity drug launch as ‘encouraging’ even though GLP-1 tablets appear to be lagging behind Novo’s
By healthadmin
As Eli Lilly races to launch its flagship oral drug GLP-1 Foundayo, the Indianapolis drugmaker…
As Merck considers its survival post-Keytruda, much of it will depend on the performance of…
In its new “Playing with the Heart” project, Merck is touting how high levels of…
The European Medicines Agency (EMA) has set up an advisory group aimed at boosting “confidence…
The FDA reprimanded Bayer for “attention-grabbing visuals” and “frequent scene changes” in ads for its…
Patient groups’ perceptions of drug companies with large U.S. footprints have changed over the past…
Although Teva Pharmaceutical’s multi-year growth streak showed signs of leveling off under CEO Richard Francis,…
As AstraZeneca prepares for the impact of the U.S. “most-favored nation” policy, CEO Pascal Soriot…
Three years after AbbVie lost exclusive rights to its immunology blockbuster Humira, leaving it on…
GSK’s first quarter, under CEO Luke Miels, saw its flagship shingles vaccine Shingrix set a…